A jury begins deliberations in the 1st trial over DePuy Orthopaedics' Pinnacle metal-on-metal hip implant.
A new line of spinal implants from Medtronic makes its debut on the global stage.
Medtronic (NYSE:MDT) said it's introduced a new line of spinal implants made of a titanium-plastic combination for interbody fusion procedures.
CE Mark approval expands the company's portfolio of cardiac rhythm devices with MRI compatibility.
St. Jude Medical lands European approval to market its Tendril STS and IsoFlex Optim leads as safe for MRI scanning, adding that the company's just getting started on a larger MRI-safe campaign.
New data from CardioMEMs CHAMPION clinical trial shows that the company's implanted pulmonary artery pressure monitor helps reduce heart failure hospitalizations without compromising kidney function in patients with renal failure.
St. Jude Medical (NYSE:STJ) subsidiary CardioMEMs touted new study results this week showing that its implanted heart monitor is safe and effective in patients with chronic kidney disease.
New generations of hip and knee replacement implants offer little in terms of safety and durability compared with their older counterparts, according to a study published this week in The BMJ.
A meta-analysis of new generations of knee and hip replacement devices could bode ill for orthopedics makers.
In a study published this week in The BMJ, researchers warned that many innovative new implants may actually have worse durability and safety profiles than their predecessors.
Titan Spine offers patients a 1-time free replacement should they need revision for an implant from the Endoskeleton line of interbody fusion devices.
Titan Spine announced this week that it's offering a new series of warranties for its Endoskeleton line of interbody spinal fusion implants, promising a 1-time free revision surgery within 5 years.